ROR1 expression	Mantle Cell Lymphoma	ROR1 expression	Mantle Cell Lymphoma	MK-2140 Sensitive: D – Preclinical MK-2140 Sensitive : D	MK-2140 Sensitive: D – Preclinical MK-2140 Sensitive : D
ROR1 positive	Chronic Lymphocytic Leukemia	ROR1 positive	Chronic Lymphocytic Leukemia	MK-2140 Sensitive: D – Preclinical MK-2140 Sensitive : D	MK-2140 Sensitive: D – Preclinical MK-2140 Sensitive : D
ROR1 expression	Acute Lymphocytic Leukemia	ROR1 expression	Acute Lymphocytic Leukemia	MK-2140 Sensitive: D – Preclinical MK-2140 Sensitive : D	MK-2140 Sensitive: D – Preclinical MK-2140 Sensitive : D
ROR1 expression	Acute Lymphocytic Leukemia	ROR1 expression	Acute Lymphocytic Leukemia	VLS-211 Sensitive: D – Preclinical VLS-211 Sensitive : D	VLS-211 Sensitive: D – Preclinical VLS-211 Sensitive : D
ROR1 underexpression	Solid Tumor	ROR1 underexpression	Solid Tumor	STRO-003 Sensitive: D – Preclinical STRO-003 Sensitive : D	STRO-003 Sensitive: D – Preclinical STRO-003 Sensitive : D
ROR1 expression	Hematological Malignancies	ROR1 expression	Hematological Malignancies	CS5001 Sensitive: D – Preclinical CS5001 Sensitive : D	CS5001 Sensitive: D – Preclinical CS5001 Sensitive : D
ROR1 expression	Solid Tumor	ROR1 expression	Solid Tumor	CS5001 Sensitive: D – Preclinical CS5001 Sensitive : D	CS5001 Sensitive: D – Preclinical CS5001 Sensitive : D
ROR1 expression	Mantle Cell Lymphoma	ROR1 expression	Mantle Cell Lymphoma	MK-2140 Sensitive: D – Preclinical MK-2140 Sensitive : D	MK-2140 Sensitive: D – Preclinical MK-2140 Sensitive : D
ROR1 positive	Leukemia	ROR1 positive	Leukemia	NBE-002 Sensitive: D – Preclinical NBE-002 Sensitive : D	NBE-002 Sensitive: D – Preclinical NBE-002 Sensitive : D
ROR1 expression	Triple Negative Breast Cancer	ROR1 expression	Triple Negative Breast Cancer	NBE-002 Sensitive: D – Preclinical NBE-002 Sensitive : D	NBE-002 Sensitive: D – Preclinical NBE-002 Sensitive : D

ROR1-targeted antibody-drug conjugate

ROR1-targeted antibody-drug conjugate

Associations(10)

Associations
(10)